Inflammatory Responses in the Atria: Should They Stay or Should They Go?

Overview

Journal Heart Rhythm

Publisher Elsevier

Specialty Cardiology & Vascular Diseases

Date 2010 Nov 9

PMID 21056699

Citations 1

Authors

Heather S Duffy

Affiliations

Soon will be listed here.

Citing Articles

Role of connexins and pannexins in cardiovascular physiology.

Meens M, Kwak B, Duffy H Cell Mol Life Sci. 2015; 72(15):2779-92.

PMID: 26091747 PMC: 11113959. DOI: 10.1007/s00018-015-1959-2.

References

Lakshminarayan K, Solid C, Collins A, Anderson D, Herzog C . Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002). Stroke. 2006; 37(8):1969-74. DOI: 10.1161/01.STR.0000230607.07928.17. View

Lawrence T, Fong C . The resolution of inflammation: anti-inflammatory roles for NF-kappaB. Int J Biochem Cell Biol. 2009; 42(4):519-23. DOI: 10.1016/j.biocel.2009.12.016. View

Jiang C, Ting A, Seed B . PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998; 391(6662):82-6. DOI: 10.1038/34184. View

Lin C, Pan C . Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cell Mol Life Sci. 2008; 65(10):1489-508. PMC: 11131653. DOI: 10.1007/s00018-008-7408-8. View

Alves T, Ferreira L, Wajngarten M, Busatto G . Cardiac disorders as risk factors for Alzheimer's disease. J Alzheimers Dis. 2010; 20(3):749-63. DOI: 10.3233/JAD-2010-091561. View

Hirsch E, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel P . The role of glial reaction and inflammation in Parkinson's disease. Ann N Y Acad Sci. 2003; 991:214-28. DOI: 10.1111/j.1749-6632.2003.tb07478.x. View

Krische D . The glitazones: proceed with caution. West J Med. 2000; 173(1):54-7. PMC: 1070979. DOI: 10.1136/ewjm.173.1.54. View

Kume O, Takahashi N, Wakisaka O, Nagano-Torigoe Y, Teshima Y, Nakagawa M . Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. Heart Rhythm. 2010; 8(2):278-85. DOI: 10.1016/j.hrthm.2010.10.029. View

Lal H, Verma S, Foster D, Golden H, Reneau J, Watson L . Integrins and proximal signaling mechanisms in cardiovascular disease. Front Biosci (Landmark Ed). 2009; 14(6):2307-34. DOI: 10.2741/3381. View

10.

Shimano M, Tsuji Y, Inden Y, Kitamura K, Uchikawa T, Harata S . Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure. Heart Rhythm. 2008; 5(3):451-9. DOI: 10.1016/j.hrthm.2007.12.010. View

11.

Pershadsingh H . Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?. Expert Opin Investig Drugs. 2004; 13(3):215-28. DOI: 10.1517/13543784.13.3.215. View

12.

Sertznig P, Seifert M, Tilgen W, Reichrath J . Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases. Am J Clin Dermatol. 2007; 9(1):15-31. DOI: 10.2165/00128071-200809010-00002. View

13.

Yamashita T, Sekiguchi A, Iwasaki Y, Date T, Sagara K, Tanabe H . Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J. 2009; 74(2):262-70. DOI: 10.1253/circj.cj-09-0644. View

14.

Gillies P, Dunn C . Pioglitazone. Drugs. 2000; 60(2):333-43; discussion 344-5. DOI: 10.2165/00003495-200060020-00009. View

15.

Burstein B, Qi X, Yeh Y, Calderone A, Nattel S . Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling. Cardiovasc Res. 2007; 76(3):442-52. DOI: 10.1016/j.cardiores.2007.07.013. View

16.

Koppen A, Kalkhoven E . Brown vs white adipocytes: the PPARgamma coregulator story. FEBS Lett. 2010; 584(15):3250-9. DOI: 10.1016/j.febslet.2010.06.035. View

17.

Hsueh W, Law R . PPARgamma and atherosclerosis: effects on cell growth and movement. Arterioscler Thromb Vasc Biol. 2001; 21(12):1891-5. DOI: 10.1161/hq1201.100261. View

18.

Sanoski C . Clinical, economic, and quality of life impact of atrial fibrillation. J Manag Care Pharm. 2009; 15(6 Suppl B):S4-9. PMC: 10442900. DOI: 10.18553/jmcp.2009.15.s6-b.4. View

19.

Jha R . Thiazolidinediones--the new insulin enhancers. Clin Exp Hypertens. 1999; 21(1-2):157-66. DOI: 10.3109/10641969909068658. View

20.

Duffy H, Wit A . Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol. 2007; 44(1):4-13. PMC: 2243184. DOI: 10.1016/j.yjmcc.2007.08.016. View